6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Sofgen Pharma S.A.
Filed: January 12, 2022
Period of Report: January 12, 2022
Accession Number: 0001213900-22-001751

View Document ↗ View on SEC.gov ↗